导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.20% | 258/1050 |
| 近一周 | -2.18% | 482/1104 |
| 近一月 | -4.72% | 583/1102 |
| 近一季 | -10.97% | 712/1092 |
| 近半年 | 3.75% | 344/1070 |
| 近一年 | 12.46% | 322/1018 |
| 近两年 | 101.71% | 185/926 |
| 近三年 | 53.04% | 236/834 |
| 成立以来 | 114.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.82% 353/1070 |
30.83% 310/1101 |
- - |
- - |
| 2025 | 37.36% 360/1065 |
7.92% 229/1014 |
0.71% 635/1038 |
35.02% 273/1050 |
-6.39% 763/1065 |
| 2024 | 0.42% 569/1011 |
-10.39% 780/960 |
-4.44% 600/983 |
14.82% 243/991 |
2.13% 231/1011 |
| 2023 | -3.11% 164/952 |
4.73% 343/880 |
3.23% 65/895 |
-7.75% 483/915 |
-2.85% 315/952 |
| 2022 | -21.36% 385/867 |
-21.41% 598/773 |
8.52% 327/806 |
-10.47% 279/845 |
2.99% 277/867 |
| 2021 | 16.32% 183/740 |
-7.85% 444/580 |
11.47% 319/659 |
1.74% 191/704 |
11.30% 50/740 |
| 2020 | 48.44% 243/554 |
0.73% 148/419 |
27.60% 151/466 |
11.85% 207/517 |
3.25% 462/554 |
| 2019 | 60.77% 75/410 |
22.86% 841/1146 |
-0.84% 436/1228 |
12.11% 76/390 |
17.71% 26/410 |
| 2018 | -33.85% 260/349 |
- - |
-8.40% 372/990 |
-11.44% 837/1000 |
-13.30% 769/1080 |
| 2017 | 15.43% 99/285 |
- - |
- - |
- - |
- - |
| 2016 | -16.23% 99/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇添富民营新动力股票 VS. 东吴新产业精选股票A(580008) |